The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Combined oral contraceptives: venous thrombosis
Open accessAbstract
BACKGROUND: Combined oral contraceptive (COC) use has been associated with venous thrombosis (VT) (i.e., deep venous thrombosis and pulmonary embolism). The VT risk has been evaluated for many estrogen doses and progestagen types contained in COC but no comprehensive comparison involving commonly used COC is available. OBJECTIVES: To provide a comprehensive overview of the risk of venous thrombosis in women using different combined oral contraceptives. SEARCH METHODS: Electronic databases (Pubmed, Embase, Web of Science, Cochrane, CINAHL, Academic Search Premier and ScienceDirect) were searched in 22 April 2013 for eligible studies, without language restrictions. SELECTION CRITERIA: We selected studies including healthy women taking COC with VT as outcome. DATA COLLECTION AND ANALYSIS: The primary outcome of interest was a fatal or non-fatal first event of venous thrombosis with the main focus on deep venous thrombosis or pulmonary embolism. Publications with at least 10 events in total were eligible. The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparisons. Unadjusted relative risks with 95% confidence intervals were reported.Two independent reviewers extracted data from selected studies. MAIN RESULTS: 3110 publications were retrieved through a search strategy; 25 publications reporting on 26 studies were included. Incidence of venous thrombosis in non-users from two included cohorts was 0.19 and 0.37 per 1 000 person years, in line with previously reported incidences of 0,16 per 1 000 person years. Use of combined oral contraceptives increased the risk of venous thrombosis compared with non-use (relative risk 3.5, 95% confidence interval 2.9 to 4.3). The relative risk of venous thrombosis for combined oral contraceptives with 30-35 μg ethinylestradiol and gestodene, desogestrel, cyproterone acetate, or drospirenone were similar and about 50-80% higher than for combined oral contraceptives with levonorgestrel. A dose related effect of ethinylestradiol was observed for gestodene, desogestrel, and levonorgestrel, with higher doses being associated with higher thrombosis risk. AUTHORS' CONCLUSIONS: All combined oral contraceptives investigated in this analysis were associated with an increased risk of venous thrombosis. The effect size depended both on the progestogen used and the dose of ethinylestradiol. Risk of venous thrombosis for combined oral contraceptives with 30-35 μg ethinylestradiol and gestodene, desogestrel, cyproterone acetate and drospirenone were similar, and about 50-80% higher than with levonorgestrel. The combined oral contraceptive with the lowest possible dose of ethinylestradiol and good compliance should be prescribed-that is, 30 μg ethinylestradiol with levonorgestrel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
The Epidemiology of Venous Thromboembolism
White, R. H. (2003) · Circulation · doi:10.1161/01.cir.0000078468.11849.66 · Cited by 2,310
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Incidence and mortality of venous thrombosis: a population‐based study
NÆSS, I. A., CHRISTIANSEN, S. C., ROMUNDSTAD, P., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTRØM, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02450.x · Cited by 1,413
Self-citationWhite, I. R., Barrett, J. K., Jackson, D., & Higgins, J. P. T. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1045 · Cited by 1,114
Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Self-citationNatural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Universities and tobacco money: Some universities are accomplices in the tobacco epidemic
Cohen, J. E. (2001) · BMJ · doi:10.1136/bmj.323.7303.1 · Cited by 943
Accuracy of clinical assessment of deep-vein thrombosis
Wells, P., Hirsh, J., Anderson, D., Lensing, A. A., Foster, G., Kearon, C., Weitz, J., D'Ovidio, R., Cogo, A., Prandoni, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92535-x · Cited by 798
Research works printed but not linked: 31
- Farmer, 1996, Safety of modern oral contraceptives, Lancet, 347, 259
- Samuelsson, 2004, Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users, Acta Obstet Gynecol Scand, 83, 674, 10.1111/j.0001-6349.2004.00574.x · doi:10.1111/j.0001-6349.2004.00574.x
- Amundsen, 2000, Tidsskr, Nor Laegeforen, 120, 326
- Austin, 2009, Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women, Am J Obstet Gynecol, 200, 620. e1-620.e3, 10.1016/j.ajog.2009.01.038 · doi:10.1016/j.ajog.2009.01.038
- Barsoum, 2010, A population-based case-control study, Thrombosis Research, 126, 373-8
- Bernstein, 1986, Pulmonary Embolism in Adolescents, AJDC, 140, 667
- Bonifacj, 1997, Case control studies of the risk factors for deep-vein thrombosis in an adult population hospitalized in internal medicine, Rev Epidemiol Sante Publique, 45, 465
- Burnhill, 1999, Int J Fertil, Womens Med, 44, 19
- Diddle, 1978, Oral contraceptives steroids and thrombophlebitis, J Tenn Med Assoc, 71, 22-26
- Fuertes, 1971, Thrombophlebitis among oral contraceptives for contraception, Obstet Gynecol, 38, 259
- Heuser, 2004, Specific oral contraceptive use and venous thromboembolism resulting in hospital admission, N Z M J, 117, U1176
- Anonymous, 1976, IPPF, Med Bull, 10, 2
- Kieler, 2003, Thromboembolism and combined oral contraceptives. Spontaneous reporting of adverse drug reactions indicate at least similar risk with themost recent contraceptives, Läkartidningen, 100, 3050
- Lambrekht, 1986, [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases], Khirurgiia (Mosk), 12, 90
- Lawrenson, 2000, Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?, Contraception, 62, 21S-28S, 10.1016/S0010-7824(00)00147-5 · doi:10.1016/s0010-7824(00)00147-5
- Lewis, 1997, The role of bias in observational studies, Contraception, 55, 189
- Lis, 1993, A concurrent cohort study of oral contraceptive use and cardiovascular risks, Pharmacoepidemiol Drug Saf, 2, 51, 10.1002/pds.2630020107 · doi:10.1002/pds.2630020107
- Ludwig, 1970, Ovulationshemmer und Venenerkrankungen, Ergebnisse der Angiologie und Phlebologie, 4, 81-102
- Meurer, 2001, What is the risk of venous thromboembolism (VT) among women taking third generation oral contraceptives ((COCs) in comparison with those taking contraceptives containing levonorgestrel?, The Journal of Family Practice, 50, 108
- Overgaard, 1986, [Venous thromboembolic disease and oral contraceptives], Ugeskr Laeger, 148, 2348
- Poulter, 1996, Safety of combined oral contraceptive pills (letter), Lancet, 347, 547
- Reed, 2012, VTE risk in users of combined oral contraceptives: Impact of a 24-day regimen containing drospirenone, Pharmacoepidemiology and Drug Safety, Conference, 169
- Seigel, 1969, Oral contraceptives and relative risk of death from venous and pulmonary thromboembolism in the United States, American Journal of Epidemiology, 90, 11, 10.1093/oxfordjournals.aje.a121045 · doi:10.1093/oxfordjournals.aje.a121045
- Tosetto, 2003, Prevalence and risk factors of venoud non-fatal venous thromboembolism in the active population of the VITA project, J Thromb Haermost, 1, 1724, 10.1046/j.1538-7836.2003.00313.x · doi:10.1046/j.1538-7836.2003.00313.x
- Tsankova, Ginekol, 2010, 49, 8
- Vallee, [Risk of venous thromboembolism among users of third-generation oral contraceptives], Presse Med, 30, 535
- Worralurt, 2005, Risk factors of venous thromboembolism (VT) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience, J Med Assoc Thai, 88, 1502
- Henzl, 2000, Pharmacology of progestins: 17 alpha-hydroxyprogesterone derivatives and progestins of the first and second generation, 101
- Kuhl, 1998, Dienogest, Drugs, 56, 834, 10.2165/00003495-199856050-00008 · doi:10.2165/00003495-199856050-00008
- Qaseem, 2007, The Joint American Academy of Family Physicians/American College of Physicians Panel on deep venous thrombosis/pulmonary embolism. Practice guideline from the American Academy of Family Physicians and the American College of Physicians, Annals of Family Medicine, 5, 57, 10.1370/afm.667 · doi:10.1370/afm.667
- Wharton, 1988, Lower dose pills, Population Reports, 16, 1
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Sex differences in the epidemiology, clinical features, and pathophysiology of migraine
Vetvik, K. G., & MacGregor, E. A. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30293-9 · Cited by 728
Pastori, D., Cormaci, V. M., Marucci, S., Franchino, G., Del Sole, F., Capozza, A., Fallarino, A., Corso, C., Valeriani, E., Menichelli, D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043169 · Cited by 324
Adolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 301
Metadata
- Authors
- de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-03-03
- Volume
- 2014
- Issue
- 3
- Pages
- CD010813-CD010813
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1574745824
- Cited by
- 399
- References
- 133
- FWCI
- 19.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined oral contraceptives: venous thrombosis. https://app.cochat.ai/papers/10.1002/14651858.cd010813.pub2
- The paper
- de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M. (2014). Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd010813.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.